Will we still have antibiotics in 50 years? We asked 7 global experts

Healthed

writer

Healthed

Healthed

André O. Hudson, Rochester Institute of Technology; Fidelma Fitzpatrick, RCSI University of Medicine and Health Sciences; Juliana Côrrea, Escola de Administração de Empresas de São Paulo da Fundação Getúlio Vargas (FGV/EAESP); Lori L. Burrows, McMaster University; Raúl Rivas González, Universidad de Salamanca; Roy Robins-Browne, The University of Melbourne, and Yori Yuliandra, Universitas Andalas

Almost since antibiotics were first discovered, we’ve been aware bacteria can learn how to overcome these medicines, a phenomenon known as antimicrobial resistance.

The World Health Organization says we’re currently losing to the bugs, with resistance increasing and too few new antibiotics in the pipeline.

We wanted to know whether experts around the world think we will still have effective antibiotics in 50 years. Seven out of seven experts said yes.


Seven green tick marks in a row

The Conversation


André O. Hudson, Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology; Fidelma Fitzpatrick, Consultant Microbiologist, Beaumont Hospital, Dublin, Ireland and Professor and Head of Department, Clinical Microbiology, RCSI University of Medicine and Health Sciences; Juliana Côrrea, Pesquisadora de pós-doutorado em saúde pública, Escola de Administração de Empresas de São Paulo da Fundação Getúlio Vargas (FGV/EAESP); Lori L. Burrows, Professor of Biocchemistry and Biomedical Sciences, McMaster University; Raúl Rivas González, Catedrático de Microbiología. Miembro de la Sociedad Española de Microbiología., Universidad de Salamanca; Roy Robins-Browne, Honorary Professorial Fellow, medical microbiology, The University of Melbourne, and Yori Yuliandra, Associate Professor of Pharmaceutical Sciences, Universitas Andalas

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Deborah Bateson AM

Prof Deborah Bateson AM

The Natural Estrogen Debate: A Focus on Combined Oral Contraception

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes

Dr Gabby Mahoney

Dr Gabby Mahoney

Eczema Management Practical Tips

Prof Rodney Baber AM

Prof Rodney Baber AM

Menopausal Hormone Therapy and its Cardiovascular Benefits

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Healthed

writer

Healthed

Test your knowledge

Recent articles

Latest GP poll

In your perception, how has Donald Trump's election to the US and related political discourse in the media concerning vaccine safety impact on your patients' willingness to follow Australian government recommended vaccinations?

Very negative impact

0%

Somewhat negative impact

0%

No noticeable impact

0%

Somewhat positive impact

0%

Very positive impact

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

MHT and its cardiovascular benefits

Tuesday 28th October, 7pm - 9pm AEDT

Speaker

Prof Rodney Baber AM

Obstetrician and Gynaecologist; Clinical Professor, Obstetrics and Gynaecology, The University of Sydney

We invite you to our next free webcast, where Prof Rod Baber will present on menopausal hormone therapy. Up to 4 hours CPD. RACGP & ACRRM accredited.